Shots:
The US FDA has approved Tauklarify (florquinitau F 18 injection/ MK-6240) for PET of the brain in adults with cognitive impairment who are being evaluated for Alzheimer’s disease to identify pts with tau neurofibrillary tangle (NFT) pathology
Approval was supported by Study 1 & 2 assessing Tauklarify (IV, 185 MBq) PET images from >500…
